Nomifénsime能抑制多巴胺的再吸收或刺激多巴胺释放,伕多巴胺的神经传递作用受到激活,而Domperidone是多巴胺受体阻滞剂,作者在同一病人中结合应用二种药物进行试验,认为对鉴别功能性和瘤肿性泌乳素血症有诊断价值。本文研究了41个病人均有血浆泌乳素(简称PRL)升高,其中女38例,几乎全部有闭径或月径失调,男性3例有阳萎无泌乳。 Nomifénsime inhibits dopamine reuptake or stimulates dopamine release, and dopamine neurotransmission is activated, whereas Domperidone is a dopamine receptor blocker. The authors used two drugs in combination in the same patient to perform the test, arguing that functional and Tumorous prolactinemia has diagnostic value. This article studied 41 patients with elevated plasma prolactin (referred to as PRL), including 38 females, almost all closed or misaligned, and 3 men with impotence without lactation.